Cerveau Technologies, Inc. and Enigma Biomedical Group, Inc., Sign Research Agreement with Centre for Addiction and Mental Health (CAMH), Toronto Posted on November 20, 2017May 25, 2020 by dev_team
Cerveau Technologies, Inc. Signs Research Agreement with Wisconsin Alzheimer’s Disease Research Center Posted on March 6, 2017May 25, 2020 by dev_team
Cerveau Technologies, Inc. Signs License Agreement with Merck for Novel Investigational Tau Imaging Agent Posted on January 5, 2017May 25, 2020 by dev_team
Collaborators Login